Going from a "9-5" company to "24/7" in just a few months has been challenging for Fulgent Genetics, but employees are happy to be contributing to the much needed supply of COVID-19 tests. Fulgent's at-home test kit was recently authorized by the FDA, and antibody testing is also now being offered. What role will testing play going forward, especially as companies try to figure out how to get employees back to the office? Take a listen to find out as chief commercial officer Brandon Perthuis explains it all to host Rishi Desai. If you like this podcast, please share it on your social channels. You

can also subscribe to the series and check out all of our episodes at

www.osmosis.org/podcast